2024
|
Invention
|
Stable levothyroxine compositions in aprotic polar solvents.
The present invention concerns the ... |
|
G/S
|
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary trac... |
|
G/S
|
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, ... |
|
Invention
|
Methods for producing stable therapeutic formulations in aprotic polar solvents.
Certain embodim... |
|
Invention
|
Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same. ... |
|
Invention
|
Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufa... |
|
G/S
|
Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnosti... |
|
G/S
|
Pharmaceutical preparations for in vivo diagnostic use;
pharmaceutical preparations for diagnost... |
|
Invention
|
Methods of treating disease with levoketoconazole.
Provided herein is a method of administering ... |
2023
|
Invention
|
Sustained release injectable therapeutic formulations using aprotic polar solvents.
The present ... |
|
Invention
|
Stable levothyroxine compositions in aprotic polar solvents. The present invention concerns the u... |
|
Invention
|
Sustained release injectable formulations using aprotic polar solvents. The present invention con... |
|
Invention
|
Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes.
Certain ... |
2022
|
Invention
|
Injectable high concentration pharmaceutical formulations and methods of manufacturing and use th... |
|
Invention
|
Methods of treating disease with levoketoconazole. Provided herein is a method of administering l... |
2021
|
G/S
|
Pharmaceutical research and development; pharmaceutical drug formulation and development services... |
|
G/S
|
Pharmaceutical preparations for the treatment of diseases
and conditions, namely, alimentary tra... |
|
Invention
|
Precipitation resistant small molecule drug formulations. Embodiments of the invention are direct... |
|
Invention
|
Stable formulations for parenteral injection of peptide drugs.
Stable formulations for parentera... |
|
G/S
|
Providing information on the topics of diabetes and pharmaceuticals for treating diabetes. |
|
G/S
|
Pharmaceutical products for the treatment of diabetes and
metabolic diseases; medical apparatus,... |
2020
|
Invention
|
Methods and compositions for treating diabetes, metabolic syndrome and other conditions. Pharmace... |
|
G/S
|
Providing information on the topics of diabetes and pharmaceuticals for treating diabetes |
|
Invention
|
Stable formulations for parenteral injection of small molecule drugs. Disclosed is a stable liqui... |
2019
|
Invention
|
Treatment of post-bariatric hypoglycemia using mini-dose stable glucagon.
Post-bariatric hypogly... |
|
Invention
|
Treatment of post-bariatric hypoglycemia using mini-dose stable glucagon. Post-bariatric hypoglyc... |
2018
|
Invention
|
Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes. Certain e... |
|
G/S
|
Pharmaceutical products for the treatment of diabetes and
metabolic diseases; pharmaceutical pro... |
|
Invention
|
Methods for treating congenital hyperinsulinism.
A method of treating congenital hyperinsulinism... |
|
Invention
|
Methods for treating congenital hyperinsulinism. A method of treating congenital hyperinsulinism ... |
|
G/S
|
Pharmaceutical products for the treatment of diabetes and metabolic diseases. Medical apparatus, ... |
2017
|
G/S
|
providing information in the field of pharmaceuticals and medicines; providing information relati... |
|
G/S
|
Pharmaceutical preparations for the treatment of diseases and conditions, namely, metabolic and a... |
|
Invention
|
Methods for producing stable therapeutic formulations in aprotic polar solvents. Certain embodime... |
2016
|
Invention
|
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents. Certain... |
|
Invention
|
Methods for producing stable therapeutic formulations in aproti c polar solvents. Certain embodim... |
|
Invention
|
Methods for producing stable therapeutic formulations in aprotic polar solvents. Certain em... |
|
Invention
|
Use of low dose glucagon.
The present invention provides methods for controlling or reducing cal... |
2015
|
Invention
|
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes. This disc... |